Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medical Legal
Amarin v. FDA and Public Meeting On Off-Label Promotion Signal An Important…
2015 could prove to be a significant year for how the Food and Drug Administration approaches drug companies’ off-label speech.…
Owner Of Durable Medical Supply Company Sentenced to 6 ½ Years In Prison
Last week, the owner of a durable medical equipment (DME) supply company was sentenced to 6 ½ years in prison for her role in…
FDA Announces Consent Decree with Medtronic Over Alleged Quality…
Yesterday, the Food and Drug Administration (FDA) announced the filing of a consent decree with Medtronic and two…
Health Diagnostics Lab Settles With DOJ; Enters Corporate Integrity…
The Department of Justice has announced the official settlement with Health Diagnostics Laboratory Inc. (HDL), of Richmond,…
GlaxoSmithKline Plans Adjustments To Its Sales Incentive Program
GlaxoSmithKline’s 2012 Corporate Integrity Agreement made mandatory the company’s “Patient First” program (or a…
Doctor’s Article Counters The “Myths That Undermine Medical…
Thomas Stossel, American Cancer Society Professor of Medicine at Harvard Medical School and a visiting scholar at the American…
DOJ Targets Physicians For Accepting Bribes In Exchange For Referrals
Last week we posted a comprehensive look at the increased scrutiny into laboratories that engage in referrals with…
Laboratory Referral Arrangements Under the Gun
Referral arrangements between laboratories and physicians have received a lot of scrutiny lately. Last week, it was…
Judge Dismisses Off-Label and Kickback Allegations Against Bristol-Myers…
District Court Judge William Bertelsman recently dismissed False Claims Act (FCA) allegations against Bristol-Myers…
BioChemics, Inc. Pays the SEC $17.9 Million For Allegedly Misrepresenting…
BioChemics, Inc., a Massachusetts-based biopharmaceutical company was ordered Wednesday to pay a total of almost $18…